Assessment of the effects of renal impairment and smoking on the pharmacokinetics of a single oral dose of the soluble guanylate cyclase stimulator riociguat (BAY 63-2521).
about
Assessment of the effects of renal impairment and smoking on the pharmacokinetics of a single oral dose of the soluble guanylate cyclase stimulator riociguat (BAY 63-2521).
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Assessment of the effects of r ...... lator riociguat (BAY 63-2521).
@en
type
label
Assessment of the effects of r ...... lator riociguat (BAY 63-2521).
@en
prefLabel
Assessment of the effects of r ...... lator riociguat (BAY 63-2521).
@en
P2093
P2860
P356
P1476
Assessment of the effects of r ...... lator riociguat (BAY 63-2521).
@en
P2093
Anja Schmidt
Corina Becker
Georg Wensing
Reiner Frey
Sigrun Unger
Wolfgang Mück
P2860
P304
P356
10.1086/685017
P433
P577
2016-03-01T00:00:00Z